You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
-
Is this deal advantageous for Celgene? BeiGene (ADR) has surged nearly 28% as of now.
- RobertPhillips900
- Thread
-
biopharma
biotech
cancer treatment
healthcare
immuno-oncology
- Replies: 1
- Forum: Celgene